Table 1.
baseline characteristics of patients
|
Recombinant human thyroid-stimulating hormone group |
Thyroid hormone withdrawal group |
||||
|---|---|---|---|---|---|
| 1·1 GBq (n=110) | 3·7 GBq (n=108) | 1·1 GBq (n=107) | 3·7 GBq (n=109) | ||
| Age, years | 44 (34–55; 20–82) | 44 (36–53; 21–76) | 45 (38–53; 17–73) | 43 (35–53; 18–77) | |
| Sex | |||||
| Women | 77 (70%) | 92 (85%) | 79 (74%) | 78 (72%) | |
| Men | 33 (30%) | 16 (15%) | 28 (26%) | 31 (28%) | |
| T stage | |||||
| T1 | 32 (29%) | 31 (29%) | 33 (31%) | 32 (29%) | |
| T2 | 52 (47%) | 52 (48%) | 51 (48%) | 50 (46%) | |
| T3 | 25 (23%) | 25 (23%) | 23 (22%) | 27 (25%) | |
| Unreported | 1 (1%) | 0 | 0 | 0 | |
| N stage | |||||
| N0 | 66 (60%) | 62 (57%) | 65 (61%) | 63 (58%) | |
| N1 | 17 (16%) | 18 (17%) | 15 (14%) | 17 (16%) | |
| Unknown | 27 (25%) | 28 (26%) | 27 (25%) | 29 (27%) | |
| Surgery type | |||||
| Near total | 2 (2%) | 0 | 0 | 1 (1%) | |
| Completion | 62 (56%) | 71 (66%) | 74 (69%) | 58 (53%) | |
| Total | 46 (42%) | 34 (32%) | 31 (29%) | 49 (45%) | |
| Unknown | 0 | 3 (3%) | 2 (2%) | 1 (1%) | |
Data are n (%) or median (IQR; range).